Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361346![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3-yl)amino) benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 325 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361363![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo ...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 249 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361365![]() (3-neopentyl-N- (1H-pyrazolo[3,4- b]pyridin-3-yl)be...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 884 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361366![]() (3-propyl-N-(1H-pyrazolo [4,3-b]pyridin-3- yl)benzo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 56 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361368![]() (3-(tert-butyl)-N-(1H- pyrazolo[4,3-b]pyridin- 3-yl...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 329 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361372![]() (N-(1H-pyrazolo[3,4-b] pyridin-3-yl)-3- (trifluorom...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.24E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361379![]() (3-cyclopropyl-N- (1H-pyrazolo [3,4-b]pyrazin-3-yl)...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 61.1 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361392![]() (3-((4,4-difluoropiperidin- 1-yl)methyl)-N- (1H-pyr...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 81.1 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361404![]() (3-((3,3-difluoropiperidin- 1-yl)methyl)-N-(1H- pyr...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 101 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361405![]() (1-(4-(6-((1H-pyrazolo [3,4-b]pyrazin-3-yl) amino)b...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 154 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361407![]() ((4-(6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)ben...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 388 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361350![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 306 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361357![]() ((6-((1H-pyrazolo[4,3-b] pyridin-3-yl)amino) benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.45E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361364![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 50 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361368![]() (3-(tert-butyl)-N-(1H- pyrazolo[4,3-b]pyridin- 3-yl...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361377![]() (1-(4-(6-((1H- pyrazolo[4,3-b] pyridin-3-yl)amino) ...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 199 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361383![]() (3-ethyl-N-(1H- pyrazolo[4,3-b] pyridin-3- yl)isoth...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 38.3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361387![]() (N-(1H-pyrazolo[4,3-b] pyiridn-3-yl)-3- (thiophen-3...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 216 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361389![]() ((6-((1H-pyrazolo[4,3-b] pyridin-3-yl)amino) isothi...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361397![]() (3-(morpholinomethyl)- N-(1H- pyrazolo[3,4-b]pyridi...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361399![]() (3-((4-(tert-butyl)piperidin- 1-yl)methyl)-N-(1H- p...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.13E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361406![]() (1-(4-(6-((1H- pyrazolo[3,4-b] pyridin-3-yl) amino)...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 409 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361370![]() (3-neopentyl-N-(1H- pyrazolo[3,4- b]pyrazin-3-yl) i...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 99.5 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361375![]() (4-(6-((1H-pyrazolo[3,4-b] pyrazin-3-yl)amino)benzo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.53E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361376![]() ((6-((1H-pyrazolo[3,4-b] pyrazin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 827 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361382![]() (3-(sec-butyl)-N-(1H- pyrazolo[4,3-b]pyridin- 3-yl)...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 54.2 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361385![]() (3-phenyl-N-(1H-pyrazolo [4,3-b]pyridin-3- yl)benzo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 226 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361386![]() (3-phenyl-N-(1H-pyrazolo [3,4-b]pyridin-3- yl)benzo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.04E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361388![]() (N-(1H-pyrazolo[3,4-b] pyrazin-3-yl)-3- (thiophen-3...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 144 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361345![]() (3-neopentyl-N- (1H-pyrazolo[4,3- b]pyridin-3-yl)be...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 284 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361348![]() ((6-((1H-pyrazolo[4,3-b] pyridin-3-yl)amino) benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 60 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361352![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 233 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361353![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.34E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361359![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 85 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361360![]() ((6-((1H-pyrazolo[4,3-b] pyridin-3-yl) amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 607 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361362![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 408 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361384![]() (3-ethyl-N-(1H- pyrazolo[3,4-b] pyridin-3-yl)isothi...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361393![]() (3-((4-fluoropiperidin- 1-yl)methyl)-N-(1H- pyrazol...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 247 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361396![]() (3-(morpholinomethyl)- N-(1H- pyrazolo[4,3-b]pyridi...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 630 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361401![]() ((S)-3-((2- methylmorpholino) methyl)-N-(1H- pyrazo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 353 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361349![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3-yl) amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 303 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361351![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3-yl) amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 136 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361367![]() (3-propyl-N-(1H- pyrazolo[3,4-b] pyrazine-3- yl)ben...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23.4 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361395![]() (3-(((3,3-difluorocyclobutyl) (methyl)amino)methyl)...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 568 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361344![]() (3-methyl-N- (1H-pyrazolo[4,3-b] pyridin-3- yl)benz...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 187 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361347![]() (6-((1H-pyrazolo[4,3-b] pyridin- 3-yl)amino)-N-(3,3...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361356![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361358![]() (6-((1H-pyrazolo[4,3-b] pyridin-3- yl)amino)-N-(3,3...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 164 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361391![]() (3-(piperidin-1- ylmethyl)-N-(1H- pyrazolo[3,4-b]py...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.56E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361400![]() (N-(1H-pyrazolo[4,3-b] pyridin-3-yl)-3- (pyrrolidin...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.74E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361408![]() ((4-(6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)ben...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361361![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 517 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361371![]() (3-neopentyl-N-(1H- pyrazolo[3,4- b]pyridin-3-yl) i...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 119 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361374![]() (8-(6-((1H-pyrazolo[3,4-b] pyrazin-3-yl)amino) benz...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361380![]() (2-(6-((1H-pyrazolo [4,3-b]pyridin- 3-yl)amino)benz...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361381![]() (3-methyl-N-(1H-pyrazolo [4,3-b]pyridin-3- yl)isoth...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 157 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361390![]() (3-methyl-N-(1H-pyrazolo [3,4-b]pyridin-3- yl)isoth...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361398![]() (3-((4-(tert-butyl)piperidin- 1-yl)methyl)-N-(1H- p...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.39E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361403![]() (3-((3,3-difluoropiperidin- 1-yl)methyl)-N-(1H- pyr...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55.9 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361354![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361355![]() ((6-((1H-pyrazolo [4,3-b]pyridin-3- yl)amino)benzo[...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361373![]() (6-((1H-pyrazolo[3,4-b] pyrazin-3- yl)amino)-N-(3,3...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 42.6 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361378![]() (3-cyclopropyl-N- (1H-pyrazolo [4,3-b]pyridin-3-yl)...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 78.2 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361394![]() (3-(((3,3-difluoro- cyclobutyl) (methyl)amino)methy...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 334 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metabotropic glutamate receptor 4 (Homo sapiens (Human)) | BDBM361402![]() (3-((2,2- dimethylmorpholino) methyl)-N- (1H-pyrazo...) | Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
Vanderbilt University US Patent | Assay Description In the first mode, a range of concentrations of the disclosed compounds are added to cells, followed by a single fixed concentration of agonist. If t... | US Patent US10221172 (2019) BindingDB Entry DOI: 10.7270/Q2N58PN2 | |||||||||||
More data for this Ligand-Target Pair |